25/03-10   -   Press releases

Altuglas International launches new acrylic resins for Medical Devices applications with Exceptional Chemical Resistance.

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impact-modified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

Altuglas® Medical Resins meet USP Class VI and ISO 10993 Parts 4 & 5 requirements, are Bisphenol A (BPA) free, and offer excellent optical transparency combined with outstanding bonding characteristics, scratch resistance, and sterilization recovery.

These and other characteristics make Altuglas® Medical Resins a good choice for transparent medical devices.

Altuglas International has a long history in Medical Device applications. For over 30 years, Altuglas® VS-UVT and Impact-modified Altuglas® SG acrylics find use in fluid contact and drug delivery applications, such as syringe components, filter housings, blood dialyzers, and renal cassettes.

More about Altuglas International:
Altuglas International, a wholly owned subsidiary of the ARKEMA Group, is world leader in PMMA, manufacturing 20% of world demand in the form of sheet, block and resin.